Related Experiment Video
Updated: Jul 25, 2026
09:08
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Drug discovery from natural products
Vincent P Gullo1, James McAlpine, Kin S Lam
1Cetek Corporation, 260 Cedar Hill Street, Marlborough, MA 01752, USA. v.gullo@cetek.com
Journal of Industrial Microbiology & Biotechnology
|March 18, 2006
Summary
Natural products offer promising therapeutic agents for cancer and infectious diseases. Advances in genetics and marine exploration accelerate the discovery of novel compounds targeting disease pathways.
Area of Science:
- Pharmacology and Natural Products Chemistry
- Drug Discovery and Development
- Microbial Genetics
Background:
- Natural product compounds are a rich source of therapeutic agents.
- Recent drug discovery efforts focus on cancer, resistant bacteria, viruses, and immunosuppressive disorders.
- Understanding the genetics of secondary metabolism in actinomycetes and exploring marine environments are key discovery avenues.
Purpose of the Study:
- To review recent progress in drug discovery from natural sources.
- To highlight novel compounds and their mechanisms of action.
- To showcase natural products as tools for understanding disease pathways.
Main Methods:
- Leveraging advances in the genetics of secondary metabolism in actinomycetes.
- Exploring diverse environments, particularly the marine ecosystem.
- Applying new high-throughput screening technologies.
- Utilizing novel natural products to elucidate biological targets and pathways.
Main Results:
- Identification of numerous natural product compounds with therapeutic potential.
- Development of compounds targeting cancer, resistant infections, and immune disorders.
- Discovery of compounds that inhibit novel drug targets.
- Natural products serve as valuable tools for biological pathway research.
Conclusions:
- Natural product drug discovery remains a vital area for developing new therapeutics.
- Interdisciplinary approaches combining genetics, environmental exploration, and advanced screening are crucial.
- Novel natural products offer unique opportunities to combat diseases and understand biological mechanisms.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
10:24A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...